This October, Raymour & Flanigan is partnering with the American Cancer Society in the fight against breast cancer.
Breast Cancer is the most common cancer type in women. In fact, in 2020, 279,100 new cases of invasive breast cancer will be diagnosed and 48,530 new cases of carcinoma in situ (CIS) will be diagnosed.
Together, we envision a future where our daughters – our children – will no longer live with the threat of breast cancer. We can’t and won’t allow progress to be put on hold because of COVID-19. We must be bolder, braver, and stronger than ever before.
With your support, vital research won’t stop. The Society’s investments in research have contributed to countless major breakthroughs related to breast cancer.
Thank you for your support!